PDGFB and bilateral striopallidodentate calcinosis: Among additional non-motor complaints, headache has been reported as relevant in 1/3 of PFBC patients in a Japanese study, especially in PDGFB and SLC20A2 mutation carriers [23], having a potential influence on quality of life and therapeutic implications [23,24,25].